Conmed (CNMD) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Conmed Corporation  (NYSE: CNMD)


Conmed's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Conmed's ROA in the second quarter of 2026?
Conmed Corporation achieved a return on average assets (ROA) of 2.44 % in its second quarter of 2026, this is above CNMD's average return on assets of 2.18%.
Conmed Corporations assets during the 12 months ending in the second quarter of 2026 are valued at $2 billion

ROA has improved compared to 2.36% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 183 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 1745, from total ROA ranking in the first quarter of 2026 at 2136.

What is ROA?



Return On Assets (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -1.21 % 0.75 % 0.85 % 0.29 % 1.87 %
Y / Y Net Income Change 7.7 % 129.09 % -50.41 % -94.16 % -28.54 %
Net Income (TTM) in million 56 55 47 64 110
Return On Assets (TTM) 2.44 % 2.36 % 2.03 % 2.77 % 4.77 %
CNMD's Total Ranking # 1745 # 2136 # 1653 # 1230 # 1168
Total Assets (TTM) in million 2,300 2,315 2,326 2,322 2,328
Seq. Total Assets Change -0.63 % -0.46 % 0.14 % -0.26 % 1.34 %
Seq. Net Income Change 66.84 % -17.39 % 485.48 % -86.65 % 254.89 %



Return On Assets Company Ranking
Within: No.
Industry # 54
Sector # 184
Overall # 1713

Return On Assets Statistics
High Average Low
5.75 %
2.18 %
-6.18 %
(Dec 31 2024)   (Jun 30 2022)





Financial Statements
Conmed's Assets $ 2,300 million CNMD's Balance sheet
Conmed's Income $ 23 million Quarterly CNMD's Income Statement
CNMD's Income by Division See CNMD's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
(Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
Y / Y Total Assets Change 0.85 % 0.27 % 0.11 % 30.1 % 0.82 %
Total Assets in million 2,326 2,306 2,300 2,298 1,766
Y / Y Net Income Change -64.47 % 105.44 % - - 557.16 %
Net Income in million 47 132 64 -81 63
Annual Return On Assets 2.02 % 5.74 % 2.8 % -3.51 % 3.54 %




Comment on CNMD's ROA in the fiscal year ending 2025
In the fiscal year 2025 Conmed's ROA decreased compared to previous year to 2.02 %, due to deterioration of net income -64.47 % to $47.06 million, from $132.42 million a year ago, as CNMD's assets were $2,325.75 million.


More Return On Assets Ratios
CNMD's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CNMD's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CNMD's Competitors
Subscribers only: Roa for Conmed's Suppliers
Subscribers only: Return On Assets for CNMD's Customers

You may also want to know
CNMD's Roi CNMD's Inventory Turnover Ratio CNMD's Growth Rates CNMD's Dividend Comparisons
CNMD's Profitability Ratios CNMD's Asset Turnover Ratio CNMD's Dividend Growth
CNMD's Roe CNMD's Valuation Ratios CNMD's Financial Strength Ratios CNMD's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Align Technology inc   6.56 %
Corcept Therapeutics Inc  6.45 %
Brightspring Health Services Inc   5.93 %
Amneal Pharmaceuticals Inc   5.90 %
Siga Technologies Inc  5.73 %
Medtronic Plc  5.71 %
Labcorp Holdings Inc   5.40 %
Merit Medical Systems Inc  5.34 %
Sotera Health Company  5.03 %
Vericel Corporation  5.02 %
Kewaunee Scientific Corporation  4.96 %
Pacs Group Inc   4.78 %
Amphastar Pharmaceuticals Inc   4.70 %
Abbvie Inc   4.68 %
The Cooper Companies Inc   4.57 %
IMPACT BIOMEDICAL INC.  4.47 %
Nrc Health  4.31 %
Cadre Holdings inc   4.29 %
The Pennant Group Inc   4.14 %
U S Physical Therapy Inc  4.08 %
Haemonetics Corporation  3.99 %
Henry Schein Inc   3.79 %
Integer Holdings Corporation  3.76 %
Zimmer Biomet Holdings Inc   3.51 %
Ardent Health Inc   3.22 %
Community Health Systems Inc   3.17 %
Vaso Corporation  2.92 %
Collegium Pharmaceutical Inc   2.72 %
National Vision Holdings Inc   2.53 %
Conmed Corporation  2.44 %


Date modified: 2026-08-13T05:53:08+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.